MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cordis'. Sat, 03 Sep 2011 02:38:10 +0100 http://www.medworm.com/index.php?rid=4560592&cid=t_131167_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FI1z98X2z8YI%2F And so the sorry saga of Johnson & Johnson manufacturing problems continues. This time, though, the FDA has tagged the health care giant for problems at its Cordis stent facility in San German, Puerto Rico. Over a two-year period, the plant failed to follow up a protocol failure and to ensure devices conformed to specifications (read the letter here). To date, manufacturing issues plaguing J&J involved screw ups at McNeil Consumer Healthcare plants that make over-the-counter meds. In fact, one plant in Fort Washington, Pa., which is where McNeil offices are based, is now shuttered and being re-tooled. However, another is located in Las Piedras , Puerto Rico, further indicating J&J units are unable to rectify problems near and far. The manufacturing problems at the Las Piedra... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4560592 Tue, 08 Mar 2011 17:19:19 +0100 4560592 http://www.medworm.com/index.php?rid=4522291&cid=t_131167_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FEacgP4fZABY%2F And so another work week is about to draw to a close. And this means daydreaming about the weekend. Our agenda includes visiting with a favorite aunt and uncle, taking the short people to assorted sports activities and tackling our overwhelming to-do list. What about you? Will you make time to exercise? Catch a movie? You can always prepare your taxes (and perhaps your payments could narrow the deficit). Whatever you do, be safe and have a wonderful time. See you soon… Samsung And Quintiles Partner To Make Biologics (Bloomberg News) Elan And Celgene Settle Patent Lawsuit Over Abraxane (Reuters) Plague Kills Scientist In First Lab Case In 50 Years (Bloomberg News) UK Gang Jailed For Counterfeit Mecidines Plot (Securing Pharma) FDA Rejects Pfizer And Protalix Med For Gaucher’s (B... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4522291 Fri, 25 Feb 2011 13:04:10 +0100 4522291 http://www.medworm.com/index.php?rid=4419453&cid=t_131167_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FXql_GCjRfw8%2F Welcome to the working week. We hope your weekend was refreshing and relaxing. Now, of course, the time has come to resume the routine of meetings and deadlines. To cope, we are, once again, armed with a cup of stimulation - our flavor today is chocolate raspberry truffle - and invite you to join us. Meanwhile, here are some interesting tidbits to begin the day. Hope your day goes well and do stay in touch. We enjoy hearing what goes on in your world… FDA OKs Novartis Meningitis Vaccine In Children, No Infants (Bloomberg News) Radiologist Wins $482M In Stent Patent Suit Against J&J (Star-Ledger of NJ) Pfizer Order To Pay $142M Over Neurontin Marketing Is Upheld (MarketWatch) Glaxo Settles Avandia Suit On Eve Of Trial (Bloomberg News) Dr. Reddy’s Gets Court Approval To Sell... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4419453 Mon, 31 Jan 2011 12:51:11 +0100 4419453 http://www.medworm.com/index.php?rid=3433165&cid=t_131167_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fuf65sY_uqao%2F Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Michael Durand has joined Resolute Communications as managing director of its New York office. He was the founding director of Porter Novelli’s global health care practice and also served as managing director of health... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3433165 Fri, 02 Apr 2010 12:20:05 +0100 3433165 http://www.medworm.com/index.php?rid=2074612&cid=t_131167_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2F823ZmwRO-qs%2F Children around the world are born with this extremely rare congenital  heart defect. The child in the photo is Zhan Weiyuan, you will find his complete story by clicking on his name.   ABC News: Four-year-old Zhang Weiyuan  of China has a condition called pentalogy of Cantrell in which the heart protrudes from the body.Zhang is shown here at Shengjing Hospital in Shenyang, in northeast China’s Liaoning province Nov. 21.Doctors usually try surgery to correct the exceedingly rare condition, which leaves the heart vulnerable to injury if untreated. An active two year old toddler in Florida celebrated Christmas with his family, full of energy and life. Two years ago Naseem was born with his heart outside his chest (Ectopia Cordis). At the time of birth surgery was ... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=2074612 Mon, 29 Dec 2008 17:08:59 +0100 2074612 http://www.medworm.com/index.php?rid=1996332&cid=t_131167_87_f&fid=34935&url=http%3A%2F%2Fmedicine.com.my%2Fwp%2F%3Fp%3D5420 Four-year-old Zhang Weiyuan of China has a condition called pentalogy of Cantrell in which the heart protrudes from the body. read more | digg story What a rarity. Features of the Pentalogy of Cantrell: * Omphalocele * Anterior diaphragmatic hernia * Sternal cleft * Ectopia cordis * Intracardiac defect: either a ventricular septal defect or a diverticulum of the left ventricle a Boy With Heart Outside Chest (Viewer Discretion Advised) (Source: Malaysian Medical Resources) Malaysian Medical Resources blogs http://www.medworm.com/rss/comments.php?id=1996332 Thu, 27 Nov 2008 05:00:00 +0100 1996332 http://www.medworm.com/index.php?rid=1888459&cid=t_131167_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F423691950%2F Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here’s a new approach we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Surface Logix hired Keith Dionne as ceo and president, who was previously ceo at Alantos Pharmaceuticals, where he sold the company to Amgen for more than $300 million in cash. Prior to Alantos, Dionne held senior-... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1888459 Fri, 17 Oct 2008 12:10:13 +0100 1888459 http://www.medworm.com/index.php?rid=1802930&cid=t_131167_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F394684642%2F Normally, when you hear someone complain about direct-to-consumer advertising, it has to do with prescription drugs. But the Senate Special Committee on Aging believes there are just as many troubling issues when it comes to DTC ads for medical devices. So a hearing is scheduled for Wedneday morning. The committee’s chairman, Herb Kohl, a Democrat from Wisconsin, tells The New York Times he’s holding the hearing because he believes the FDA may have to increase scrutiny of device ads, much as it has done for drugs. “The medical device industry is just beginning to get into the game,” he says. DTC ads on TV and on the Internet amounted to $193 million last year, a small fraction of spending on drug ads, according to TNS Media Intelligence, a consulting firm, the paper writes.... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1802930 Wed, 17 Sep 2008 03:23:40 +0100 1802930 http://www.medworm.com/index.php?rid=1516781&cid=t_131167_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F311212770%2F The way things are going, Cordis will need a different kind of stent to prop up its business. The latest departure is Todd Pope, worldwide president of Cordis, who left yesterday, according to an investor note by Larry Biegelsen, an analyst at Wachovia Capital Markets. He points out that Pope had responsibility for nearly all Cordis activities, and a replacement hasn’t been announced. This marks the seventh senior Cordis person to recently leave or announce plans to leave, Biegelsen adds. Let’s keep track - Rick Anderson, Cordis company group chairman; David Kandazri, chief medical officer; Mark Valentine, vp of sales; Brian Firth, vp of health economics and his replacement, Liesl Cooper; and Denis Donohue, vp of clinical affairs will leave this summer. Sales rep turnover is a... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1516781 Fri, 13 Jun 2008 14:58:52 +0100 1516781 http://www.medworm.com/index.php?rid=1158449&cid=t_131167_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F218200771%2F This has been quite a busy week, which only makes things more fun and interesting. We hope your week is going as well as ours. To help you along, here are a few of the latest nuggets. So grab a cup of something hot, and dig in… FDA Wants More Info On Glaxo’s Cervarix Vaccine (MarketWatch.com) Roche Extends Ventana Bid - Again (Arizona Daily Star) Enbrel Effective In Treating Psoriasis In Kids: Study (US News/HealthDay) Cordis Sues Abbott For Fifth Time Over Stent Patent (Medill.Northwestern.edu) India’s Drugmakers Want Government R&D Tax Break (PharmaTimes) ImpactRx Buys Paragon Research (press release) Share / E-mail (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1158449 Thu, 17 Jan 2008 12:00:53 +0100 1158449 http://www.medworm.com/index.php?rid=1071125&cid=t_131167_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F195498481%2F On one hand, the health care giant is reorganizing - cutting 4,300 jobs to save up to $1.6 billion - thanks to problems in its Cordis stent business, among other issues. On the other hand, J&J wants to boost the stent business, which has been hammered by repeatedly by safety concerns. Now, though, its Cordis unit is spending untold dollars to run direct-to-consumer TV ads and some say the campaign, called “Life Wide Open,” may accomplish very little. (Here’s the ad). For one, some docs think the idea of directly advertising stents is inappropriate, reflecting the ongoing debate over whether stents are implanted too often in patients who may do better with other treatments, The New York Times writes. “It’s deplorable,” William Boden, a professor of medicine at t... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1071125 Wed, 05 Dec 2007 12:40:13 +0100 1071125 http://www.medworm.com/index.php?rid=839134&cid=t_131167_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F152023146%2F The health care giant is reacting to new research showing that patients given drug-coated stents after an acute heart attack are nearly 5 percent more likely to die a year or more later than those with bare-metal stents. The two-year analysis of 2,300 patients in 14 countries adds further uncertainty over the safety of the drug-coated models, including J&J’s Cypher. Doctors at the European Society of Cardiology said the finding showed the need to be very selective about giving drug stents to the right patients. Gabriel Steg of the Hospital Bichat-Claude Bernard in Paris followed patients who were given stents after suffering the most deadly kind of heart attack. For the first six months, those on drug stents did as well as those on bare ones. But after 180 days, their paths dive... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=839134 Tue, 04 Sep 2007 13:13:52 +0100 839134 http://www.medworm.com/index.php?rid=728727&cid=t_131167_150_f&fid=35781&url=http%3A%2F%2Fwww.qdinformation.com%2Fqdisblog%2F2007%2F03%2F20%2Frep-waxman-requests-information-from-pharmaceutical%2F Seems Representative Henry Waxman (D, CA) wants to hear from the following companies about the following drugs for the following reasons: Lilly: Zyprexa (bipolar). Inappropriate promotion for off-label use AstraZeneca: Seroquel (schizophrenia). Inappropriate marketing Boston Scientific: drug coated stents. Safety and off-label use Cordis: drug coated stents. Safety and off-label use Cephalon: Actiq (narcotic lollipop) and Fentora (narcotic lozenge). Inappropriate marketing PharmaLive: Rep. Waxman Requests Research and Marketing Information from Pharmaceutical and Medical Device Companies : Here are the letters that were sent. WaxmanLilly.pdf WaxmanAZ.pdf WaxmanBoston.pdf WaxmanCordis.pdf WaxmanCephalon.pdf The longest letter went to Cephalon over their narcotic products . All the letters a... QDIS Blog blogs http://www.medworm.com/rss/comments.php?id=728727 Tue, 20 Mar 2007 15:19:56 +0100 728727